poseltinib (HM71224) / Hanmi 
Welcome,         Profile    Billing    Logout  

1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
poseltinib (HM71224) / Hanmi
GPL study, NCT05335018: GPL in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma

Recruiting
2
76
RoW
Glofitamab, Poseltinib, Lenalidomide
Seoul National University Hospital
Relapsed/Refractory Diffuse Large B Cell Lymphoma
11/25
11/26

Download Options